Quantcast

Latest schizophrenia Stories

2014-02-12 23:27:42

The Brain & Behavior Research Foundation names 10 recent discoveries funded by its NARSAD Grants. (PRWEB) February 12, 2014 The Brain & Behavior Research Foundation Names 10 Recent Discoveries Funded by its NARSAD Grants That Will Help Understand, Treat and Cure Mental Illnesses The Brain & Behavior Research Foundation has named 10 recent discoveries, funded by its NARSAD Grants, that provide new insight into the mysteries of the brain and potential treatments for people with...

2014-02-11 16:25:38

First liquid formulation clozapine for treatment-resistant schizophrenia DUBLIN, Feb. 11, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced U.S. commercial availability of Versacloz(TM) (clozapine, USP) oral suspension, the first and only oral suspension clozapine for severely ill treatment-resistant schizophrenia patients or those at risk of recurrent suicidal behavior with schizophrenia or schizoaffective disorder. "We are pleased to offer patients with...

2014-02-11 08:31:37

-- PDE10 Target Engagement Continues to Increase with Well-Tolerated Doses -- SEATTLE, Feb. 11, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced additional positive data from its Phase 1 program for OMS824, the lead compound in Omeros' phosphodiesterase 10 (PDE10) program. This clinical trial evaluated the extent to which OMS824 binds to PDE10, an enzyme expressed in the region of the brain that has been linked to a wide range of diseases that affect cognition....

2014-02-07 23:01:26

The Firm is evaluating Risperdal lawsuits on behalf of men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) February 07, 2014 With Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continuing to move forward in courts around the country, Bernstein Liebhard LLP notes the publication of yet another report detailing a rise in pediatric use of Risperdal and other...

2014-02-05 08:28:36

-- Enrollment in Huntington's Phase 2 Trial Expected Soon -- SEATTLE, Feb. 5, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, for the treatment of cognitive impairment in patients with Huntington's disease. OMS824 selectively inhibits PDE10, an enzyme expressed in areas of the brain linked to a wide range of diseases...

2014-02-04 23:02:09

Wright & Schulte LLC is Investigating Risperdal Lawsuits on Behalf of Patients Who Used the Atypical Antipsychotic and Developed Gynecomastia, also Known as Male Breast Growth. Columbus, OH (PRWEB) February 04, 2014 Wright & Schulte LLC, an experienced law firm representing clients in Risperdal lawsuits, announces they have launched a new Facebook page to provide the public with the most up-to-date information regarding the ongoing litigation of Risperdal gynecomastia claims. The...

2014-02-04 12:28:45

NEW YORK, Feb. 4, 2014 /PRNewswire/ -- As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/) continue to move forward in U.S. courts, a new analysis out of Germany indicates that more children in that country are being treated with antipsychotic drugs. The analysis, which appeared last month in Deutsches Arzteblatt International, looked at data collected by a German health insurer, and found that the use of such medications among children and adolescents grew significantly...

2014-01-29 23:32:05

60 Minutes interview with Virginia Senator Creigh Deeds spotlights disastrous consequences of a failed mental health care system. New book, A Voice out of Nowhere by Janice Holly Booth, follows another family's experience with inadequate mental health care to a deadly, violent conclusion. Charlotte, North Carolina (PRWEB) January 29, 2014 It’s a story that’s becoming all too tragically familiar: a family seeks help for their mentally ill child, only to be turned away or given...

2014-01-29 08:29:25

- Data expand potential indications both within schizophrenia and to other neuropsychiatric disorders - SEATTLE, Jan. 29, 2014 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic pharmacokinetics when administered alone and concomitantly with approved antipsychotic agents in patients...

2014-01-22 23:29:26

According to a recent research, individuals who have psychotic disorders are using alcohol, tobacco and drugs more when compared to the general population. All the academic events concerning the latest psychological, psychiatric and physical researches in relation with the substance addiction and their results can be found on Eventegg. (PRWEB) January 22, 2014 According to a recent research, individuals who have psychotic disorders are using alcohol, tobacco and drugs more when compared...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related